Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 3
1969 1
1970 1
1971 2
1972 1
1973 3
1975 1
1976 9
1977 9
1978 7
1979 8
1980 12
1981 11
1982 14
1983 18
1984 25
1985 36
1986 30
1987 11
1988 24
1989 21
1990 25
1991 25
1992 20
1993 13
1994 19
1995 25
1996 14
1997 23
1998 22
1999 30
2000 39
2001 16
2002 41
2003 24
2004 24
2005 46
2006 43
2007 40
2008 40
2009 46
2010 51
2011 49
2012 72
2013 76
2014 70
2015 89
2016 99
2017 114
2018 113
2019 94
2020 104
2021 112
2022 114
2023 132
2024 51

Text availability

Article attribute

Article type

Publication date

Search Results

1,930 results

Results by year

Filters applied: . Clear all
Page 1
Ceftriaxone and the Risk of Ventricular Arrhythmia, Cardiac Arrest, and Death Among Patients Receiving Lansoprazole.
Bai AD, Wilkinson A, Almufleh A, Rai M, Razak F, Verma AA, Srivastava S. Bai AD, et al. JAMA Netw Open. 2023 Oct 2;6(10):e2339893. doi: 10.1001/jamanetworkopen.2023.39893. JAMA Netw Open. 2023. PMID: 37883084 Free PMC article.
MAIN OUTCOMES AND MEASURES: The primary outcome was a composite of ventricular arrhythmia or cardiac arrest that occurred after hospital admission. ...Propensity-score weighting was used to adjust for covariates including hospital site, demographic characteristics, …
MAIN OUTCOMES AND MEASURES: The primary outcome was a composite of ventricular arrhythmia or cardiac arrest that occurred afte …
Amiodarone and thyroid physiology, pathophysiology, diagnosis and management.
Trohman RG, Sharma PS, McAninch EA, Bianco AC. Trohman RG, et al. Trends Cardiovasc Med. 2019 Jul;29(5):285-295. doi: 10.1016/j.tcm.2018.09.005. Epub 2018 Sep 20. Trends Cardiovasc Med. 2019. PMID: 30309693 Free PMC article.
We performed a systematic search of MEDLINE to identify peer-reviewed clinical trials, randomized controlled trials, meta-analyses, and other clinically relevant studies. ...Amiodarone was searched using the terms adverse effects, hypothyroidism, myxedema, hyperthyr …
We performed a systematic search of MEDLINE to identify peer-reviewed clinical trials, randomized controlled trials, meta-anal …
Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial.
Perera D, Morgan HP, Ryan M, Dodd M, Clayton T, O'Kane PD, Greenwood JP, Walsh SJ, Weerackody R, McDiarmid A, Amin-Youssef G, Strange J, Modi B, Lockie T, Hogrefe K, Ahmed FZ, Behan M, Jenkins N, Abdelaal E, Anderson M, Watkins S, Evans R, Rinaldi CA, Petrie MC; REVIVED-BCIS2 Investigators. Perera D, et al. Circulation. 2023 Sep 12;148(11):862-871. doi: 10.1161/CIRCULATIONAHA.123.065300. Epub 2023 Aug 9. Circulation. 2023. PMID: 37555345 Free PMC article. Clinical Trial.
BACKGROUND: Ventricular arrhythmia is an important cause of mortality in patients with ischemic left ventricular dysfunction. ...The mean age of participants was 69 years; 88% were male; 56% had hypertension; 41% had diabetes; and 53% had a clinical history o …
BACKGROUND: Ventricular arrhythmia is an important cause of mortality in patients with ischemic left ventricular dysfunction. …
Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF.
Curtain JP, Docherty KF, Jhund PS, Petrie MC, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Bengtsson O, Langkilde AM, Sjöstrand M, Solomon SD, McMurray JJV. Curtain JP, et al. Eur Heart J. 2021 Sep 21;42(36):3727-3738. doi: 10.1093/eurheartj/ehab560. Eur Heart J. 2021. PMID: 34448003 Free PMC article. Clinical Trial.
A serious ventricular arrhythmia was reported in 115 (2.4%) of the 4744 patients in DAPA-HF (ventricular fibrillation in 15 patients, ventricular tachycardia in 86, 'other' ventricular arrhythmia/tachyarrhythmia in 12, and torsade de pointes in 2 patie …
A serious ventricular arrhythmia was reported in 115 (2.4%) of the 4744 patients in DAPA-HF (ventricular fibrillation in 15 pa …
Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial.
Ogata H, Fukagawa M, Hirakata H, Kagimura T, Fukushima M, Akizawa T; LANDMARK Investigators and Committees. Ogata H, et al. JAMA. 2021 May 18;325(19):1946-1954. doi: 10.1001/jama.2021.4807. JAMA. 2021. PMID: 34003226 Free PMC article. Clinical Trial.
RESULTS: Among 2309 randomized patients (median age, 69 years; 40.5% women), 1851 (80.2%) completed the trial. ...However, the event rate was low, and the findings may not apply to patients at higher risk. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NC …
RESULTS: Among 2309 randomized patients (median age, 69 years; 40.5% women), 1851 (80.2%) completed the trial. ...However, the …
Improved outcomes in patients with severely depressed LVEF undergoing percutaneous coronary intervention with contemporary practices.
O'Neill WW, Anderson M, Burkhoff D, Grines CL, Kapur NK, Lansky AJ, Mannino S, McCabe JM, Alaswad K, Daggubati R, Wohns D, Meraj PM, Pinto DS, Popma JJ, Moses JW, Schreiber TL, Magnus Ohman E. O'Neill WW, et al. Am Heart J. 2022 Jun;248:139-149. doi: 10.1016/j.ahj.2022.02.006. Epub 2022 Feb 19. Am Heart J. 2022. PMID: 35192839 Free article. Clinical Trial.
This study sought to compare outcomes of the prospective, multicenter, PROTECT III study to historic patients treated with Impella in the PROTECT II randomized controlled trial. METHODS: Of 1,134 patients enrolled in PROTECT III from March 2017 to March 2020, 504 we …
This study sought to compare outcomes of the prospective, multicenter, PROTECT III study to historic patients treated with Impella in the PR …
Ventricular arrhythmias.
Flinders DC, Roberts SD. Flinders DC, et al. Prim Care. 2000 Sep;27(3):709-24;vii. doi: 10.1016/s0095-4543(05)70170-6. Prim Care. 2000. PMID: 10918676 Review.
Sudden cardiac death remains a leading cause of death in the United States. It is usually due to ventricular arrhythmia, either ventricular tachycardia or ventricular fibrillation. The probability of life threatening ventricular arrhythmia correlates c …
Sudden cardiac death remains a leading cause of death in the United States. It is usually due to ventricular arrhythmia, eithe …
Flecainide.
Falk RH, Fogel RI. Falk RH, et al. J Cardiovasc Electrophysiol. 1994 Nov;5(11):964-81. doi: 10.1111/j.1540-8167.1994.tb01136.x. J Cardiovasc Electrophysiol. 1994. PMID: 7889236 Review.
It is well absorbed and effective in suppressing isolated premature ventricular contractions (PVCs) or nonsustained ventricular arrhythmia but has only a modest efficacy when electrophysiologic testing is used as an endpoint. ...Despite the applicability of the CAST …
It is well absorbed and effective in suppressing isolated premature ventricular contractions (PVCs) or nonsustained ventricular ar …
Association of SGLT2 inhibitors with arrhythmias and sudden cardiac death in patients with type 2 diabetes or heart failure: A meta-analysis of 34 randomized controlled trials.
Fernandes GC, Fernandes A, Cardoso R, Penalver J, Knijnik L, Mitrani RD, Myerburg RJ, Goldberger JJ. Fernandes GC, et al. Heart Rhythm. 2021 Jul;18(7):1098-1105. doi: 10.1016/j.hrthm.2021.03.028. Epub 2021 Mar 20. Heart Rhythm. 2021. PMID: 33757845
METHODS: We searched PubMed and ClinicalTrials.gov. Two independent investigators identified randomized double-blind trials that compared SGLT2is with placebo or active control for adults with T2DM or HF. Primary outcomes were incident atrial arrhythmias, ventricular arrhy …
METHODS: We searched PubMed and ClinicalTrials.gov. Two independent investigators identified randomized double-blind trials that comp …
Intravenous amiodarone.
Kowey PR, Marinchak RA, Rials SJ, Filart RA. Kowey PR, et al. J Am Coll Cardiol. 1997 May;29(6):1190-8. doi: 10.1016/s0735-1097(97)00069-7. J Am Coll Cardiol. 1997. PMID: 9137212 Free article. Review.
The objectives of this review were to summarize what is known about intravenous amiodarone, including its pharmacologic and electrophysiologic effects, to review its efficacy for the treatment of patients with highly malignant ventricular arrhythmia and to provide s …
The objectives of this review were to summarize what is known about intravenous amiodarone, including its pharmacologic and electrophysiolog …
1,930 results